ArticleCancer chemotherapy and pharmacology2013

Phase I study of sorafenib in combination with everolimus (RAD001) in patients with advanced neuroendocrine tumors.

Jennifer A Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.